Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001213900-20-029062

CEO and CFO bought 114,347 shares at $5.75 ($657,495)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Purchase : show line 1 in the form +114,347 $5.75 $657,495 863,683 D
Open-market purchases · 114,347 sh · avg $5.75 · $657,495
Loading xslF345X03/ownership.xml…